from JAMA Neurology
New research provides additional evidence that statins may reduce the risk of Alzheimer’s disease. The study, published in JAMA Neurology, found regular use of one of four popular statins for at least two years was associated with a fifteen percent lower risk of Alzheimer’s for women and twelve percent lower risk for men. However, specific statins appeared to have differing results with women and men of different ethnic backgrounds. It is also known that some people have negative side-effects from some types of statins. So, consulting with your own healthcare professional regarding those differences may allow you to take full advantage of the statin regimen best suited to you.